Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Topix Skin Health is a leading provider of innovative, therapeutic skincare products, primarily serving the physician-dispensed market. Founded in 1981, the company develops and manufactures high-quality topical formulations, including its flagship brand Replenix, which is known for its green tea polyphenol technology. Topix operates a state-of-the-art, FDA-registered facility where it handles research, development, and large-scale manufacturing. The company's business model focuses on partnering with dermatologists to provide medical-grade skincare solutions for various conditions such as acne, aging, and sun damage. In 2016, Topix was acquired by New Mountain Capital to support its continued expansion and product innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Topix Skin Health.